Skip to main content
. 2022 Sep 27;9:995688. doi: 10.3389/fmed.2022.995688

TABLE 1.

Country representation for each stakeholder group.

Country Investigators (n = 82)
n (%)
DPOs/legal experts (n = 31)
n (%)
EC members (n = 39)
n (%)
Austria 2 (2%) / 3 (8%)
Belgium 13 (16%) 8 (26%) 5 (13%)
Bulgaria / 5 (16%) /
Croatia 3 (4%) / 1 (3%)
Czechia 2 (2%) 1 (3%) /
Denmark / 2 (7%) /
Estonia / / 1 (3%)
Finland / / 2 (5%)
France 7 (9%) 2 (7%) /
Germany 6 (7%) 3 (10%) 3 (8%)
Greece / / 3 (8%)
Ireland 1 (1%) / 1 (3%)
Italy 14 (17%) 1 (3%) /
Latvia / / 2 (5%)
Lithuania 3 (4%) / 2 (5%)
Luxembourg 1 (1%) / 1 (3%)
Malta 1 (1%) / /
The Netherlands 8 (10%) 1 (3%) 2 (5%)
Poland 1 (1%) 2 (7%) 2 (5%)
Portugal 5 (6%) / 4 (10%)
Slovakia 1 (1%) / 1 (3%)
Slovenia 2 (2%) / /
Spain 4 (5%) / 2 (5%)
Sweden 1 (1%) 1 (3%) /
United Kingdom 7 (9%) 5 (16%) 4 (10%)